China on the Move: Breaking Barriers and Accelerating Growth: Clinical Trials, Drug Approvals, and Cross-Border Data ...
China’s life sciences sector is undergoing significant transformation due to recent technological advancements, legislative changes, and regulatory reforms aimed at balancing risk mitigation with innovation. As explored in this GT Advisory, these shifts …